Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 3 1Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 55Breast Neoplasms 38Prostatic Neoplasms 29Lung Neoplasms 28Multiple Myeloma 22Neoplasms 19Ovarian Neoplasms 17Colorectal Neoplasms 17Leukemia, Lymphocytic, Chronic, B-Cell 16Neoplasm Metastasis 15Parkinson Disease 4, Autosomal Dominant Lewy Body 14Carcinoma, Renal Cell 13Endometrial Neoplasms 12Small Cell Lung Carcinoma 11Pancreatic Neoplasms 11Urinary Bladder Neoplasms 10Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Lymphoma, Follicular 9Fallopian Tube Neoplasms 9Non-Muscle Invasive Bladder Neoplasms 8Myasthenia Gravis 8Leukemia, Myeloid, Acute 8Colonic Neoplasms 8Burkitt Lymphoma 7Recurrence 6Esophageal Neoplasms 6Adenocarcinoma 6Triple Negative Breast Neoplasms 5Melanoma 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Disease × 30 days × Clear all
NCT07615101 2026-06-01

Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.

Norroy Bioscience Co., LTD

Phase 3 Not yet recruiting
365 enrolled
Genitourinary

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡